Recruiting NA Pes Planus

New treatment option for Pes Planus

Official title The Effect of Orthosis and Exercise in Pes Planus

ClinicalTrials.gov ID: NCT03494374

What this study is testing

What it's testing
There is no definite evidence for the conservative treatment of pes planus. We want to verify the combination efficacy of orthosis and toe walking exercise for the treatment of pes planus.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 3 to 10

You may be able to join if

  • Clinically diagnosed with pes planus
  • Calcaneal pitch angle \< 15 degree

You likely can't join if

  • peripheral neuropathy
  • infection
  • rheumatoid arthritis
  • operation history

The study team makes the final eligibility decision.

Where it's taking place

  • Seongnam-si, Bundang-gu, South Korea

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 3 years to 10 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Seongnam-si, Bundang-gu, South Korea. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.